Lisa B. Zaoutis, MD

faculty photo
Attending Physician, General Pediatrics, The Department of Pediatrics, CHOP
Administrative: Integrated Care Services, The Children's Hospital of Philadelphia
Administrative: Co-develop unit-base Nurse Practitioner Programs, The Children's Hospital of Philadelphia
Administrative: Medical Hospitalist Team, The Children's Hospital of Philadelphia
Supervise: Sedation Unit, The Children's Hospital of Philadelphia
Develop: General Pediatrics Overflow Team, The Children's Hospital of Philadelphia
General Pediatric Consult Services to Physical Medicine and Rehab inpatient services, The Children's Hospital of Philadelphia
Director, Pediatrics Residency Program, The Children's Hospital of Philadelphia

Contact information
Children's Hospital of Philadelphia
Pediatric Residency Program
3401 Civic Center Blvd., 9th Floor
Philadelphia, PA 19104
Office: 215-590-1699
Fax: Zaoutis1@email.chop.edu
Education:
BS (Biology)
Rensselaer Polytechnic Institute, 1981.
MD
Albany Medical College, 1983.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Site Principal Investigator for MARC-30 EMNet Study: Prospective Multicenter Study of Bronchiolitis Admissions: Etiology and Disposition. 2007-2011


“Controlled Comparison of RD Heparin versus Unfractionated Heparin for the Initial Treatment of Deep Vein Thrombosis.” 1990-1992.

“Comparison of the Safety and Efficacy of RD Heparin versus Placebo for Prevention of Coronary Artery Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA).” 1990-1992.

“Comparison of the Safety and Efficacy of RD Heparin versus Warfarin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Unilateral Elective Hip or Knee Replacement Surgery.” 1989-92.

“Comparison of the Safety and Efficacy of RD Heparin versus Aspirin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Unilateral Elective Hip or Knee Replacement Surgery.” 1989-1992.

“Comparison of the Safety and Efficacy of RD Heparin versus Unfractionated Heparin for the Prevention of Deep Vein Thrombosis in Patients Undergoing Abdominal or Pelvic Surgery for Cancer.” 1989-1992.

“A Pharmacokinetic and Safety Study of Intravenous RD Heparin in Patients with Deep Vein Thrombosis.” 1989-1991.
back to top
Last updated: 11/28/2018
The Trustees of the University of Pennsylvania